Taylor Wessing offers advice on various healthcare topics, including transaction support with particular expertise in the group formation of medical care centers. Here, the practice is regularly instructed by international private equity funds, which benefit from the cooperation with the corporate and regulatory experts, co-head Michael Stein is a key contact here. The team also comprehensively advises pharmaceutical and biotechnology companies on all aspects of medical, patent and trademark law issues as well as disputes pertaining to life sciences products, here, co-head Anja Lunze regularly takes the lead. The practice frequently cooperates with the TMC team regarding the implementation of business models across the digital healthcare sector. Karolina Lange-Kulmann (medical law) joined the partner roster in May 2023.
Testimonials
Collated independently by Legal 500 research team.
'Special expertise and many years of experience as well as excellent contacts with authorities in the German healthcare system.'
'High reliability and quality of work. Very fair treatment of clients (e.g. no unnecessary costs). High level of commitment.'
'Fast response and very good availability, very good and patient technical exchange (also with colleagues in our company who are not so well versed in legal issues), overall a very good and smooth collaboration, recommendable.'
'Very open-minded, customer-oriented and competent. The team has specialists in many different fields, which means that the problem can be viewed from several perspectives. The atmosphere in the team is very cooperative.'
'We are impressed by the team's integrated approach and their deep industry know-how. Inquiries are answered quickly, competently and in a practical manner. The understanding of problems and the creativity in solving problems, shaped by years of industry experience, are impressive.'
'Daniel Tietjen: Years of working in the life sciences industry have led to a great deal of experience and industry knowledge, which ensures not only legally competent but also strategically helpful support for our projects.'
- 'As a proven expert in the healthcare sector, Oliver Klöck will support us in implementing our strategic corporate growth, particularly in the area of our business commitment and investments in the healthcare sector.'
- 'All contacts are extremely competent in their fields, but also manage to bring overarching topics together and bring them to a successful conclusion. We also appreciate the practical workshops that are offered on various (new) topics.'
Key clients
- Abbott Laboratories
- Advanced Bionics AG
- Amedes
- Angelini Pharma
- AstraZeneca
- Azenta INC
- Bayer
- Bertelsmann
- BioSpring
- Biotest AG
- Cardior Pharmaceuticals GmbH
- Cochlear
- Daiichi Sankyo
- Dana-Farber Cancer Institute, Inc.
- DocMorris
- European Healthcare Investors
- Fachklinikum Mainschleife GmbH
- Fresenius Kabi Swiss BioSim
- Glenmark Pharmaceuticals Europe Ltd.
- Glenmark Arzneimittel GmbH
- Grünenthal
- kohlpharma AG
- Lifento
- Morphosys
- MTK-PHARMA Vertriebs-GmbH
- Mylan / Viatris
- Omnicare Pharma GmbH
- Ortivity
- Pfizer Inc.
- Primavera
- Protect Medical Holding G
- Protembis GmbH
- Radio-Onkologie-Netzwerk (RON)
- Roxall Medizin
- Sanecum (Adiuva Capital)
- STADA Arzneimittel AG
- Strehmel’s GmbH
- Sunday Natural
- Tandem Diabetes Care Europe B.V.
- Tandem Diabetes Care, Inc.
- UKE
- Vivisol Deutschland GmbH
- YZR Capital Fund GmbH & Co. KG
Work highlights
- Advising Sunday Natural Products GmbH on the sale of a stake in Sunday Natural to private equity investor CVC Capital Partners VIII (CVC Fund VIII).
- Advising Ortivity GmbH regarding a majority stake in Narconova MVZ GmbH, a practice and clinic group for anesthesiological services in North Rhine-Westphalia.
- Advising Mercurius Health on the acquisition of MEDICLIN Robert Janker Clinic.